Copyright Reports & Markets. All rights reserved.

Global Anti-infective API Market Research Report 2021

Request for Sample of this report
Buy now

1 Anti-infective API Market Overview

  • 1.1 Product Overview and Scope of Anti-infective API
  • 1.2 Anti-infective API Segment by Type
    • 1.2.1 Global Anti-infective API Market Size Growth Rate Analysis by Type 2021 VS 2027
    • 1.2.2 β-lactam Drugs
    • 1.2.3 Macrolides
    • 1.2.4 Carbapenems
    • 1.2.5 Quinolones
  • 1.3 Anti-infective API Segment by Application
    • 1.3.1 Global Anti-infective API Consumption Comparison by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Antibacterial Drugs for Systemic Use
    • 1.3.3 Antiviral Drugs for Systemic Use
    • 1.3.4 Antigen for Whole Body
    • 1.3.5 Bacteria
    • 1.3.6 Immune Serum and Immunoglobulin
    • 1.3.7 Anti-mycobacterial Drugs
    • 1.3.8 Vaccine
    • 1.3.9 Other
  • 1.4 Global Market Growth Prospects
    • 1.4.1 Global Anti-infective API Revenue Estimates and Forecasts (2016-2027)
    • 1.4.2 Global Anti-infective API Production Capacity Estimates and Forecasts (2016-2027)
    • 1.4.3 Global Anti-infective API Production Estimates and Forecasts (2016-2027)
  • 1.5 Global Market Size by Region
    • 1.5.1 Global Anti-infective API Market Size Estimates and Forecasts by Region: 2016 VS 2021 VS 2027
    • 1.5.2 North America Anti-infective API Estimates and Forecasts (2016-2027)
    • 1.5.3 Europe Anti-infective API Estimates and Forecasts (2016-2027)
    • 1.5.5 China Anti-infective API Estimates and Forecasts (2016-2027)
    • 1.5.5 Japan Anti-infective API Estimates and Forecasts (2016-2027)

2 Market Competition by Manufacturers

  • 2.1 Global Anti-infective API Production Capacity Market Share by Manufacturers (2016-2021)
  • 2.2 Global Anti-infective API Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Anti-infective API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.4 Global Anti-infective API Average Price by Manufacturers (2016-2021)
  • 2.5 Manufacturers Anti-infective API Production Sites, Area Served, Product Types
  • 2.6 Anti-infective API Market Competitive Situation and Trends
    • 2.6.1 Anti-infective API Market Concentration Rate
    • 2.6.2 Global 5 and 10 Largest Anti-infective API Players Market Share by Revenue
    • 2.6.3 Mergers & Acquisitions, Expansion

3 Production and Capacity by Region

  • 3.1 Global Production Capacity of Anti-infective API Market Share by Region (2016-2021)
  • 3.2 Global Anti-infective API Revenue Market Share by Region (2016-2021)
  • 3.3 Global Anti-infective API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.4 North America Anti-infective API Production
    • 3.4.1 North America Anti-infective API Production Growth Rate (2016-2021)
    • 3.4.2 North America Anti-infective API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.5 Europe Anti-infective API Production
    • 3.5.1 Europe Anti-infective API Production Growth Rate (2016-2021)
    • 3.5.2 Europe Anti-infective API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.6 China Anti-infective API Production
    • 3.6.1 China Anti-infective API Production Growth Rate (2016-2021)
    • 3.6.2 China Anti-infective API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.7 Japan Anti-infective API Production
    • 3.7.1 Japan Anti-infective API Production Growth Rate (2016-2021)
    • 3.7.2 Japan Anti-infective API Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Anti-infective API Consumption by Region

  • 4.1 Global Anti-infective API Consumption by Region
    • 4.1.1 Global Anti-infective API Consumption by Region
    • 4.1.2 Global Anti-infective API Consumption Market Share by Region
  • 4.2 North America
    • 4.2.1 North America Anti-infective API Consumption by Country
    • 4.2.2 United States
    • 4.2.3 Canada
  • 4.3 Europe
    • 4.3.1 Europe Anti-infective API Consumption by Country
    • 4.3.2 Germany
    • 4.3.3 France
    • 4.3.4 U.K.
    • 4.3.5 Italy
    • 4.3.6 Russia
  • 4.4 Asia Pacific
    • 4.4.1 Asia Pacific Anti-infective API Consumption by Region
    • 4.4.2 China
    • 4.4.3 Japan
    • 4.4.4 South Korea
    • 4.4.5 Taiwan
    • 4.4.6 Southeast Asia
    • 4.4.7 India
    • 4.4.8 Australia
  • 4.5 Latin America
    • 4.5.1 Latin America Anti-infective API Consumption by Country
    • 4.5.2 Mexico
    • 4.5.3 Brazil

5 Production, Revenue, Price Trend by Type

  • 5.1 Global Anti-infective API Production Market Share by Type (2016-2021)
  • 5.2 Global Anti-infective API Revenue Market Share by Type (2016-2021)
  • 5.3 Global Anti-infective API Price by Type (2016-2021)

6 Consumption Analysis by Application

  • 6.1 Global Anti-infective API Consumption Market Share by Application (2016-2021)
  • 6.2 Global Anti-infective API Consumption Growth Rate by Application (2016-2021)

7 Key Companies Profiled

  • 7.1 North China Pharmaceutical
    • 7.1.1 North China Pharmaceutical Anti-infective API Corporation Information
    • 7.1.2 North China Pharmaceutical Anti-infective API Product Portfolio
    • 7.1.3 North China Pharmaceutical Anti-infective API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.1.4 North China Pharmaceutical Main Business and Markets Served
    • 7.1.5 North China Pharmaceutical Recent Developments/Updates
  • 7.2 CSPC
    • 7.2.1 CSPC Anti-infective API Corporation Information
    • 7.2.2 CSPC Anti-infective API Product Portfolio
    • 7.2.3 CSPC Anti-infective API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.2.4 CSPC Main Business and Markets Served
    • 7.2.5 CSPC Recent Developments/Updates
  • 7.3 Harbin Pharmaceutical Group Pharmaceutical General Factory
    • 7.3.1 Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Corporation Information
    • 7.3.2 Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Product Portfolio
    • 7.3.3 Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.3.4 Harbin Pharmaceutical Group Pharmaceutical General Factory Main Business and Markets Served
    • 7.3.5 Harbin Pharmaceutical Group Pharmaceutical General Factory Recent Developments/Updates
  • 7.4 Henan Huaxing Pharmaceutical Factory
    • 7.4.1 Henan Huaxing Pharmaceutical Factory Anti-infective API Corporation Information
    • 7.4.2 Henan Huaxing Pharmaceutical Factory Anti-infective API Product Portfolio
    • 7.4.3 Henan Huaxing Pharmaceutical Factory Anti-infective API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.4.4 Henan Huaxing Pharmaceutical Factory Main Business and Markets Served
    • 7.4.5 Henan Huaxing Pharmaceutical Factory Recent Developments/Updates
  • 7.5 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical
    • 7.5.1 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Corporation Information
    • 7.5.2 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Product Portfolio
    • 7.5.3 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.5.4 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Main Business and Markets Served
    • 7.5.5 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Recent Developments/Updates
  • 7.6 Zhangjiakou Diha Pharmaceutical
    • 7.6.1 Zhangjiakou Diha Pharmaceutical Anti-infective API Corporation Information
    • 7.6.2 Zhangjiakou Diha Pharmaceutical Anti-infective API Product Portfolio
    • 7.6.3 Zhangjiakou Diha Pharmaceutical Anti-infective API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.6.4 Zhangjiakou Diha Pharmaceutical Main Business and Markets Served
    • 7.6.5 Zhangjiakou Diha Pharmaceutical Recent Developments/Updates
  • 7.7 Shandong Lukang Medicine
    • 7.7.1 Shandong Lukang Medicine Anti-infective API Corporation Information
    • 7.7.2 Shandong Lukang Medicine Anti-infective API Product Portfolio
    • 7.7.3 Shandong Lukang Medicine Anti-infective API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.7.4 Shandong Lukang Medicine Main Business and Markets Served
    • 7.7.5 Shandong Lukang Medicine Recent Developments/Updates
  • 7.8 Zhuhai United Laboratories
    • 7.8.1 Zhuhai United Laboratories Anti-infective API Corporation Information
    • 7.8.2 Zhuhai United Laboratories Anti-infective API Product Portfolio
    • 7.8.3 Zhuhai United Laboratories Anti-infective API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.8.4 Zhuhai United Laboratories Main Business and Markets Served
    • 7.7.5 Zhuhai United Laboratories Recent Developments/Updates
  • 7.9 Lunan Pharmaceutical Group
    • 7.9.1 Lunan Pharmaceutical Group Anti-infective API Corporation Information
    • 7.9.2 Lunan Pharmaceutical Group Anti-infective API Product Portfolio
    • 7.9.3 Lunan Pharmaceutical Group Anti-infective API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.9.4 Lunan Pharmaceutical Group Main Business and Markets Served
    • 7.9.5 Lunan Pharmaceutical Group Recent Developments/Updates
  • 7.10 Sandoz
    • 7.10.1 Sandoz Anti-infective API Corporation Information
    • 7.10.2 Sandoz Anti-infective API Product Portfolio
    • 7.10.3 Sandoz Anti-infective API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.10.4 Sandoz Main Business and Markets Served
    • 7.10.5 Sandoz Recent Developments/Updates

8 Anti-infective API Manufacturing Cost Analysis

  • 8.1 Anti-infective API Key Raw Materials Analysis
    • 8.1.1 Key Raw Materials
    • 8.1.2 Key Raw Materials Price Trend
    • 8.1.3 Key Suppliers of Raw Materials
  • 8.2 Proportion of Manufacturing Cost Structure
  • 8.3 Manufacturing Process Analysis of Anti-infective API
  • 8.4 Anti-infective API Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

  • 9.1 Marketing Channel
  • 9.2 Anti-infective API Distributors List
  • 9.3 Anti-infective API Customers

10 Market Dynamics

  • 10.1 Anti-infective API Industry Trends
  • 10.2 Anti-infective API Growth Drivers
  • 10.3 Anti-infective API Market Challenges
  • 10.4 Anti-infective API Market Restraints

11 Production and Supply Forecast

  • 11.1 Global Forecasted Production of Anti-infective API by Region (2022-2027)
  • 11.2 North America Anti-infective API Production, Revenue Forecast (2022-2027)
  • 11.3 Europe Anti-infective API Production, Revenue Forecast (2022-2027)
  • 11.4 China Anti-infective API Production, Revenue Forecast (2022-2027)
  • 11.5 Japan Anti-infective API Production, Revenue Forecast (2022-2027)

12 Consumption and Demand Forecast

  • 12.1 Global Forecasted Demand Analysis of Anti-infective API
  • 12.2 North America Forecasted Consumption of Anti-infective API by Country
  • 12.3 Europe Market Forecasted Consumption of Anti-infective API by Country
  • 12.4 Asia Pacific Market Forecasted Consumption of Anti-infective API by Region
  • 12.5 Latin America Forecasted Consumption of Anti-infective API by Country

13 Forecast by Type and by Application (2022-2027)

  • 13.1 Global Production, Revenue and Price Forecast by Type (2022-2027)
    • 13.1.1 Global Forecasted Production of Anti-infective API by Type (2022-2027)
    • 13.1.2 Global Forecasted Revenue of Anti-infective API by Type (2022-2027)
    • 13.1.3 Global Forecasted Price of Anti-infective API by Type (2022-2027)
  • 13.2 Global Forecasted Consumption of Anti-infective API by Application (2022-2027)

14 Research Finding and Conclusion

    15 Methodology and Data Source

    • 15.1 Methodology/Research Approach
      • 15.1.1 Research Programs/Design
      • 15.1.2 Market Size Estimation
      • 15.1.3 Market Breakdown and Data Triangulation
    • 15.2 Data Source
      • 15.2.1 Secondary Sources
      • 15.2.2 Primary Sources
    • 15.3 Author List

    The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027. by Application segment also provides consumption during the forecast period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    β-lactam Drugs
    Macrolides
    Carbapenems
    Quinolones

    Segment by Application
    Antibacterial Drugs for Systemic Use
    Antiviral Drugs for Systemic Use
    Antigen for Whole Body
    Bacteria
    Immune Serum and Immunoglobulin
    Anti-mycobacterial Drugs
    Vaccine
    Other

    By Company
    North China Pharmaceutical
    CSPC
    Harbin Pharmaceutical Group Pharmaceutical General Factory
    Henan Huaxing Pharmaceutical Factory
    Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical
    Zhangjiakou Diha Pharmaceutical
    Shandong Lukang Medicine
    Zhuhai United Laboratories
    Lunan Pharmaceutical Group
    Sandoz

    Production by Region
    North America
    Europe
    China
    Japan

    Consumption by Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Latin America
    Mexico
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    Buy now